Results 171 to 180 of about 64,721 (205)

Posttransplant EBV‐Positive Smooth Muscle Tumors in Children, Adolescents, and Young Adults: A Multi‐Institution Experience

Pediatric Blood &Cancer, Volume 72, Issue 6, June 2025.
ABSTRACT Epstein–Barr virus (EBV)‐positive smooth muscle tumors (SMTs) are rare tumors seen in immunocompromised patients. There is no clear standard of care for the management and treatment of EBV‐SMTs. Patients are often treated with chemotherapy, surgery, and/or radiation.
Meghan Haney, Kaitlin J. Devine, Ana C. Xavier, James B. Ford, Anthony N. Audino, Lynda Villagomez, Ann Kebede, Jeremy D. Rubinstein   +7 more
wiley   +1 more source

Roles of autophagy and long non-coding RNAs in gastric cancer. [PDF]

World J Gastroenterol
Luong TV, Cao MTT, Nguyen NVD, Dang HNN, Nguyen TT.   +4 more
europepmc   +1 more source

The Diagnostic Value of Plasma Small Extracellular Vesicle‐Derived CAIX Protein in Prostate Cancer and Clinically Significant Prostate Cancer: A Study on Predictive Models

The Prostate, Volume 85, Issue 8, Page 723-741, June 2025.
ABSTRACT Background Current diagnostic tools are inaccurate and not specific to prostate cancer (PCa) diagnosis. Cancer‐derived small extracellular vehicles (sEVs) play a key role in intercellular communication. In this study, we examined the diagnostic value of plasma sEV‐derived carbonic anhydrase IX (CAIX) protein for PCa and clinically significant ...
Haotian Chen, Bairen Pang, Zhihan Liu, Benjie Li, Qi Wang, Baokun Fan, Meng Han, Jie Gong, Cheng Zhou, Yingzhi Chen, Yong Li, Junhui Jiang   +11 more
wiley   +1 more source

USP37 as a novel regulator of NRF2 protein stability and chemoresistance in HCC. [PDF]

Discov Oncol
Zhang S, Ding F, Jia F, Lu X.
europepmc   +1 more source

A potential tumor suppressor role of PLK2 in glioblastoma

FEBS Open Bio, Volume 15, Issue 5, Page 856-866, May 2025.
PLK2 was consistently downregulated in GBM tissues. Overexpression of PLK2 in GBM cell lines U87MG and U251 reduced their tumorigenic potential and enhanced cell cycle arrest and apoptosis. Suggesting that PLK2 overexpression could potentially be leveraged as a therapeutic strategy to inhibit tumor progression and enhance apoptosis, providing new ...
Xiangping Xia, Peirui Wang, Hua Xiao, Qishan Ran, Yan Li, Shengtao Yao   +5 more
wiley   +1 more source

Omega-3 fatty acids: molecular weapons against chemoresistance in breast cancer. [PDF]

Cell Mol Biol Lett
Marchio V, Augimeri G, Morelli C, Vivacqua A, Giordano C, Catalano S, Sisci D, Barone I, Bonofiglio D.   +8 more
europepmc   +1 more source

Characterisation of the role played by ELMO1, GPR141 and the intergenic polymorphism rs918980 in Fuchs' dystrophy in the Indian population

FEBS Open Bio, Volume 15, Issue 5, Page 822-835, May 2025.
This study reports the upregulation of ELMO1 and GPR141 in human Fuchs' endothelial corneal dystrophy (FECD) corneal endothelium and ultraviolet A‐induced FECD mice model. A genetic association of an intergenic single nucleotide polymorphism rs918980 present between both genes is observed with FECD in the Indian population.
Susmita Sharma, Samar Kumar Basak, Sujata Das, Debasmita Pankaj Alone   +3 more
wiley   +1 more source

Correction: CREB1-BCL2 drives mitochondrial resilience in RAS GAP-dependent breast cancer chemoresistance. [PDF]

Oncogene
Man KF, Darweesh O, Hong J, Thompson A, O'Connor C, Bonaldo C, Melkonyan MN, Sun M, Patel R, Ellisen LW, Robinson T, Song D, Koh SB.   +12 more
europepmc   +1 more source

Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk‐Stratification, and Management

American Journal of Hematology, Volume 100, Issue 5, Page 860-891, May 2025.
ABSTRACT Disease Overview Acute myeloid leukemia (AML) is a bone marrow stem cell cancer that is often fatal despite available treatments. Diagnosis, risk assessment, monitoring, and therapeutic management of AML have changed dramatically in the last decade due to increased pathophysiologic understanding, improved assessment technology, and the ...
Shai Shimony, Maximilian Stahl, Richard M. Stone   +2 more
wiley   +1 more source